Desotamide B [V2I]

General Information


DRACP ID  DRACP01855

Peptide Name   Desotamide B [V2I]

Sequence  NIlLWG

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Hep-G2 Hepatoblastoma Blastoma IC50=606.8 µM SRB assay Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Vero cells: IC50=90.8 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  NCB: Asn1<--->Gly6

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  l=D-Leu

Chiral  Mix



Physicochemical Information


Formula  C29H41N7O6

Absent amino acids  ACDEFHKMPQRSTVY

Common amino acids  GILNW

Mass  67306

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  3

Net charge  0

Boman Index  647

Hydrophobicity  58.33

Aliphatic Index  130

Half Life 
  /

Extinction Coefficient cystines  5500

Absorbance 280nm  1100

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29125222

Title  Total Synthesis and Antibacterial Study of Cyclohexapeptides Desotamide B, Wollamide B and Their Analogs

Doi 10.1002/cbdv.201700414

Year  2018

Literature 2

Pubmed ID 29431987

Title  Solid-Phase Synthesis and Antibacterial Activity of Cyclohexapeptide Wollamide B Analogs

Doi 10.1021/acscombsci.7b00189

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.